RhumbLine Advisers
ZURA icon

RhumbLine Advisers’s Zura Bio ZURA Stock Holding History

RhumbLine Advisers’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,577
Closed -$47.2K – 4277
2025
Q1 		$47.2K Sell
36,577
-1,080
-3% -$1.7K ﹤0.01% 3591
2024
Q4 		$94.1K Buy
37,657
+10,231
+37% +$36.4K ﹤0.01% 3492
2024
Q3 		$111K Buy
27,426
+10,532
+62% +$39.3K ﹤0.01% 3470
2024
Q2 		$59.1K Buy
16,894
+1,371
+9% +$5.59K ﹤0.01% 3641
2024
Q1 		$39.9K Buy
15,523
+556
+4% +$1.97K ﹤0.01% 3675
2023
Q4 		$69.9K Buy
14,967
+3,768
+34% +$18.8K ﹤0.01% 3553
2023
Q3 		$73.9K Buy
11,199
+3,089
+38% +$20.6K ﹤0.01% 3553
2023
Q2 		$66.5K Buy
+8,110
New +$65.2K ﹤0.01% 3623

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

RhumbLine Advisers's ZURA Position: Q2 2025 in Review

RhumbLine Advisers sold out of Zura Bio (ZURA) in Q2 2025, closing a stake of 36,577 shares — an estimated $47.2K sold.

RhumbLine Advisers first reported a position in ZURA in Q2 2023 and held it in 8 quarters. The position peaked at $111K in Q3 2024. 65 funds tracked by Wall St. Rank hold ZURA as of Q2 2025.

  • RhumbLine Advisers reported no remaining Zura Bio position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 36,577 Zura Bio shares in Q2 2025, an estimated $47.2K.
  • RhumbLine Advisers first reported a position in Zura Bio in Q2 2023 and held it in 8 quarters.
  • RhumbLine Advisers's Zura Bio position peaked at $111K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Zura Bio as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.